ALTIERI, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 6.807
Totale 6.807
Nazione #
IT - Italia 6.807
Totale 6.807
Città #
Genova 4.584
Rapallo 915
Genoa 693
Vado Ligure 591
Bordighera 24
Totale 6.807
Nome #
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 170
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 169
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 166
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 166
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 157
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 151
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 147
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 146
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 141
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 139
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 139
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 137
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 131
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 130
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 127
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 126
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 122
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 114
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 110
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 110
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 108
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 104
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 102
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 101
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 100
Role of cell-cell bond for the viability and the function of vascular smooth muscle cells. 100
Early Age of onset of unstable angina is associated to major oxidative stress 99
Controllo antagonista di p38 e JNK nella regolazione della senescenza e di p16INK4A indotte dalla doxorubicina nei progenitori delle cellule endoteliali 98
Comparison between the potential protective mechanisms of carvedilol and atenolol against doxorubicin induced cardiac muscle cell damage and death in vitro. 94
Plasma Levels of matrix metalloproteinase-9 and matrix metalloproteinase-2 are increased in plasma of patients with heart failure 92
Elevated plasma levels of lipid peroxidation are associated to an early onset of UA 91
BASSE DOSI DI DOXORUBICINA PORTANO I CARDIOMIOCITI A MORTE TARDIVA PER CATASTROFE MITOTICA DOVUTA AD UNA ALTERATA REGOLAZIONE DELLE PROTEINE DEL TELOMERO: RUOLO DELLE MAPKs E DI p53 91
HETEROGENEITY AND DIFFERENT RELATIONSHIP WITH BIOCHEMICAL AND INFLAMMATORY BIOMARKERS FOR THE CIRCULATING CD16+ MONOCYTES SUBSETS IN ABDOMINAL AORTIC ANEURYSMS (AAA) 91
Plasma Levels of Matrix metalloproteinase-2 are increased in plasma of patients with heart failure. 90
Confronto fra meccanismi potenzialmente protettivi di carvedilolo e atenololo contro il danno e la morte di cellule muscolari cardiache indotti dalla doxorubicina in vitro. 89
UN PASTO IPERLIPIDICO INDUCE STRESS OSSIDATIVO DERIVATODALL’ATTIVITÀ DELLA MIELOPEROSSIDASI E DETERMINA L’AUMENTO DELL’ATTIVITÀ DELLE METALLOPROTEASI 89
Doxorubicin promotes metalloproteinases-2 trancriptional and zymographic activity in cardiac muscle cells via Nadph oxidase-derived reactive oxygen species. 88
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 84
Osteopontin plasma levels correlate with coronary atherosclerosis extension and in-stent restenosis in coronary artery disease patients undergoing percutaneous coronary intervention 83
Autoanticorpi contro proteine ossidate in pazienti con recente sviluppo di angina instabile. 83
ADVANCED ABDOMINAL AORTIC ANEURYSMS DISPLAY ASPECIFIC INFLAMMATORY-PROATHEROSCLEROTIC PROFILEWITH RENAL DYSFUNCTION, RAISED D-DIMER, EXPANDEDCD14++CD16+-MONOCYTES HAVING HIGH CD143 79
La doxorubicina induce nei cardiomiociti la metalloproteasi di tipo 2 attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 78
Relazione tra Stress Parietale e Risposta Infiammatoria Sistemica con Danno Miocardico in pazienti con Insufficienza Cardiaca Cronica in fase Stabile 75
Doxorubicin induces activation of Metalloproteinase-2 and –9 in cardiomyocytes through the MAPKinase pathways: protective effects of carvedilol and dexrazoxane 75
Markers of oxidative stress evaluated in patients with ischemic heart disease at the time of their first clinical manifestation. 74
Traditional risk factors for ATS do not explain major oxidative stress levels in patients with early age onset of unstable angina: possibile role for genetic factors? Population genetics of haemostatic risk factors for arterial vascular disease. 73
Il carvedilolo protegge le cellule endoteliali contro la produzione di radicali liberi e l’apoptosi indotte da doxorubicina. 73
IL SIERO POSTPRANDIALE MOSTRA EFFETTI PRO-OSSIDANTI E PROAPOPTOTICI SULLE CELLULE ENDOTELIALI 70
STRESS OSSIDATIVO E P53 MEDIANO L’INIBIZIONE DI IGF-1R INDOTTA DA DOXORUBICINA IN CELLULE MUSCOLARI CARDIACHE 69
Il carvedilolo previene la formazione di radicali liberi e il danno ossidativo indotto da doxorubicina sui cardiomiociti. 67
Insorgenza precoce di angina instabile e livelli plasmatici di perossidazione lipidica 66
Un pasto iperlipidico rende il siero pro-apoptotico per le cellule endoteliali: ruolo dell’infiammazione e stress ossidativo. 66
La doxorubicina induce apoptosi e senescenza nei progenitori delle cellule endoteliali e regola l'azione chemiotattica dei cardiomiociti nei loro confronti 66
TRATTAMENTI SEQUENZIALI CON DOSI SUB-APOPTOTICHE DI EPIDOXORUBICINA ED ANTICORPO ANTI erbB2 INDUCONO APOPTOSI NEI CARDIOMIOCITI: RUOLO CARDIOPROTETTIVO DEL DEXRAZOXANE. 65
Elevata attivita’ di metalloprteasi 2 e 9 circolanti nei pazienti con scompenso cardiaco 64
Il carvedilolo previene la perdita del potenziale di membrana mitocondriale indotta da doxorubicina nei cardiomiociti 63
Pensieri radicali: associazione di danno ossidativo proteico con angina instabile di recente insorgenza 63
Meccanismi di tossicità indotta da doxorubicina su cardiomiociti e razionale per l’uso dei farmaci protettivi nella pervenzione del danno cardiaco 62
Neutrophil-derived matrix metalloproteinase 9 is increased in patients with heart failure 62
Pazienti con manifestazione precoce di angina instabile non presentano correlazioni tra livelli di stress ossidativo e autoanticorpi diretti contro proteine ossidate. 62
Ruolo del Polimorfismo C242T della Subunità p22phox del Complesso NAD(P)H Ossidasi in Pazienti con Aterosclerosi Coronarica. 62
La doxorubicina induce le metalloproteasi 2 e –9 attraverso l’attivazione delle MAPK: ruolo protettivo del carvedilolo e del dexrazoxane., 61
La doxorubicina induce l’aumento della trascrizione e dell’attività della MMP-2 nelle cellule muscolari cardiache attraverso le specie reattive dell’ossigeno prodotte dalla NADPH ossidasi. 54
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 54
Polimorfismo nel gene cyba: possibile marcatore di suscettibilita’ genetica all’aterosclerosi 53
Oxaprozin reduces metalloproteinase-9 expression and activity in immune-complex activated human monocytes. 52
SUBSET MONOCITARI CD14 CD16 IN PAZIENTI CON SCOMPENSO CARDIACO CONGESTIZIO. 52
Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy 51
Effetto protettivo del carvedilolo contro la morte per apoptosi indotta da doxorubicina in cellule muscolari cardiache. 50
La metalloproteasi di tipo 9 proveniente dai neutrofili aumenta nei pazienti con scompenso cardiaco. 48
Le risposte infiammatorie ed ossidative indotte da un pasto iperlipidico rendono il siero postprandiale proapoptotico per le cellule endoteliali. 48
IL LEGAME CELLULA-CELLULA CONTRASTA GLI EFFETTI PROATEROGENICI DI ANGIOTENSINA II IN CELLULE MUSCOLARI LISCE DI AORTA DI RATTO 46
RIDOTTA APOPTOSI DEI LEUCOCITI POLIMORFONUCLEATI EDANNO ENDOTELIALE IN SOGGETTI AFFETTI DA SCOMPENSO CARDIACO CONGESTIZIO 46
UN PASTO AD ALTO CONTENUTO LIPIDICO DIMINUISCE IL TASSO DI APOPTOSI SPONTANEA DEI LEUCOCITI POLIMORFONUCLEATI 39
Effects of the AhR inhibitor CH-223191 on the indoxyl sulphateinduced cardiac fibroblast activation. Role of Nrf2 33
Scouting in silico different chemo-types of PDE4 inhibitors to guide the design of new anti-inflammatory/antioxidant agents 29
Inside the Mechanism of Action of Three Pyrazole Derivatives in Human Platelets and Endothelial Cells 17
Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2 14
Totale 6.856
Categoria #
all - tutte 19.661
article - articoli 16.334
book - libri 0
conference - conferenze 3.327
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.322


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.135 0 0 0 0 0 155 222 62 117 322 181 76
2020/2021295 19 29 14 19 21 31 8 27 42 31 25 29
2021/2022848 8 69 62 112 53 41 47 211 19 88 32 106
2022/20231.077 102 71 9 107 210 162 10 84 181 8 114 19
2023/2024505 15 59 9 55 45 109 24 33 57 8 24 67
2024/2025646 64 103 44 111 196 128 0 0 0 0 0 0
Totale 6.856